Delivery Order SPE2DB22D2108-SPE2DB25FU2NN
Award Date
10/11/24
Potential Completion Date
10/15/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of febuxostat 40 mg tablets. The contract has a ceiling value of $17,032.46 and a period of performance through August 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,479.78 Firm Fixed Price delivery order is for the supply of 4,565,481,718 units of the prescription medication Febuxostat 40 mg tablets. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,236.52 firm-fixed-price contract is for the supply of febuxostat 40 mg tablets. There is no set-aside designation. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for providing a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.14 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,566,025 units of the drug febuxostat 40 mg tablets. The delivery order contract, valued at $1,624.68, has a firm fixed price and an ultimate completion date of October 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $1,014.19, is for the supply of 4565560153 FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price pricing structure and an ultimate completion date of August 26, 2024. There is no set-aside designation on this contract. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the delivery of 40 milligram febuxostat tablets in 30-count packages, with a potential value of $1,423.80 and a completion date of February 2, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp serves...
The U.S. Department of Defense's Medical Supply Chain (VPDLATSMED-A) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $3,821.00 for the supply of 4565127517 - FEBUXOSTAT 40 MG TABLET 30S. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 80 mg tablets. The $1,328.20 firm fixed-price award has a period of performance through July 2024. Amerisourcebergen provides a wide range of essential pharmaceutical and medical products to federal agencies and healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,044.95 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...